Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Short-term Investments: 2023-2025

  • Zhengye Biotechnology Holding's Short-term Investments was N/A to $276.51 in Q2 2025 from the same period last year, while for Jun 2025 it was $276.51, marking a year-over-year change of. This contributed to the annual value of $197,000 for FY2024, which is 88.51% down from last year.
  • As of Q2 2025, Zhengye Biotechnology Holding's Short-term Investments stood at $276.51, which was down 99.86% from $197,000 recorded in Q4 2024.
  • In the past 5 years, Zhengye Biotechnology Holding's Short-term Investments ranged from a high of $1.7 million in Q4 2023 and a low of $276.51 during Q2 2025.
  • For the 3-year period, Zhengye Biotechnology Holding's Short-term Investments averaged around $626,540, with its median value being $197,000 (2024).
  • Data for Zhengye Biotechnology Holding's Short-term Investments shows a maximum YoY crashed of 88.29% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Zhengye Biotechnology Holding's Short-term Investments stood at $1.7 million in 2023, then slumped by 88.29% to $197,000 in 2024, then reached $276.51 in 2025.
  • Its Short-term Investments stands at $276.51 for Q2 2025, versus $197,000 for Q4 2024 and $1.7 million for Q4 2023.